Literature DB >> 15067057

CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells.

Marie Koschella1, David Voehringer, Hanspeter Pircher.   

Abstract

Injection of agonistic anti-CD40 Abs into mice has been shown to amplify weak CD8 T cell responses to poorly immunogenic compounds and to convert T cell tolerance to T cell priming. In this study we demonstrate that anti-CD40 treatment of C57BL/6 mice, without Ag delivery, led to a marked increase in the number of memory phenotype CD4 and CD8 T cells. Adoptive transfer experiments using CD40-deficient hosts further revealed that the proliferative response of memory T cells, induced by systemic CD40 signaling, was dependent on CD40 expression of host APCs. CD40 ligation in vivo induced vigorous cell division of both memory phenotype and bona fide virus-specific memory CD8 T cells in a partially IL-15-dependent manner. However, only memory phenotype, but not Ag-experienced memory CD8 T cells increased in cell number after anti-CD40 treatment in vivo. Taken together our data show that activation of APC via CD40 induces a marked bystander proliferation of memory phenotype T cells. In addition, we demonstrate that bona fide Ag-experienced memory CD8 T cells respond differently to anti-CD40-induced signals than memory phenotype CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067057     DOI: 10.4049/jimmunol.172.8.4804

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.

Authors:  Rosalind Polley; Stephanie L Sanos; Sara Prickett; Ashraful Haque; Paul M Kaye
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them.

Authors:  Jason T White; Eric W Cross; Ross M Kedl
Journal:  Nat Rev Immunol       Date:  2017-05-08       Impact factor: 53.106

3.  IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.

Authors:  Honorio Torres-Aguilar; Carmen Sánchez-Torres; Luis J Jara; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2010-06-11       Impact factor: 8.317

Review 4.  The role of bystander T cells in CNS pathology and pathogen clearance.

Authors:  Dorian B McGavern
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

5.  Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.

Authors:  David Masopust; Kaja Murali-Krishna; Rafi Ahmed
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

Review 6.  The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.

Authors:  Fanqi Jin; Fengshan Wang
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

7.  Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Authors:  Pandelakis A Koni; Anna Bolduc; Mayuko Takezaki; Yutetsu Ametani; Lei Huang; Jeffrey R Lee; Stephen L Nutt; Masahito Kamanaka; Richard A Flavell; Andrew L Mellor; Takeshi Tsubata; Michiko Shimoda
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

8.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

9.  Foreign antigen-independent memory-phenotype CD4+ T cells: a new player in innate immunity?

Authors:  Ross M Kedl; Jason T White
Journal:  Nat Rev Immunol       Date:  2018-02-26       Impact factor: 53.106

10.  Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Authors:  Cornelia Hömig-Hölzel; Caroline Hojer; Julia Rastelli; Stefano Casola; Lothar J Strobl; Werner Müller; Leticia Quintanilla-Martinez; Andreas Gewies; Jürgen Ruland; Klaus Rajewsky; Ursula Zimber-Strobl
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.